Piedmont Healthcare

Physician Preferences for Recommending Renal Denervation to Hypertensive Patients Is Influenced by Patients' Antihypertensive Medication Nonadherence Due to Medication Side Effects (2022) Wang TD, Schmieder R, Kandzari DE, Lee YH, Haro CF, Pathak A Conference contribution Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial (2022) Mahfoud F, Kandzari DE, Kario K, Townsend RR, Weber MA, Schmieder R, Tsioufis K, et al. Journal article Clinical Trial Design Principles and Outcomes Definitions for Device-Based Therapies for Hypertension: A Consensus Document From the Hypertension Academic Research Consortium (2022) Kandzari DE, Mahfoud F, Weber MA, Townsend R, Parati G, Fisher NDL, Lobo MD, et al. Journal article Long-term reduction in morning and nighttime blood pressure after renal denervation: 36-month results from SPYRAL HTN-ON MED trial (2022) Kario K, Mahfoud F, Kandzari DE, Townsend RR, Weber MA, Schmieder R, Tsioufis K, et al. Journal article A phase II, randomized, open-label, 52-week study of seladelpar in patients with primary biliary cholangitis (2022) Bowlus CL, Galambos MR, Aspinall RJ, Hirschfield GM, Jones DE, Dörffel Y, Gordon SC, et al. Journal article Reasons for antihypertensive medication nonadherence influence physician preferences for hypertension management (2021) Schmieder R, Kandzari DE, Wang TD, Lee YH, Haro C, Pathak A Conference contribution Effect of Heart Rate on the Outcome of Renal Denervation in Patients With Uncontrolled Hypertension (2021) Böhm M, Tsioufis K, Kandzari DE, Kario K, Weber MA, Schmieder R, Townsend RR, et al. Journal article Long-Term Results up to 12 Months After Catheter-Based Alcohol-Mediated Renal Denervation for Treatment of Resistant Hypertension (2021) Mahfoud F, Sievert H, Bertog S, Lauder L, Ewen S, Lengele JP, Wojakowski W, et al. Journal article Catheter-based alcohol-mediated renal denervation for the treatment of uncontrolled hypertension: design of two sham-controlled, randomized, blinded trials in the absence (TARGET BP OFF-MED) and presence (TARGET BP I) of antihypertensive medications (2021) Mahfoud F, Weber M, Schmieder R, Lobo MD, Blankestijn PJ, Persu A, Fischell TA, et al. Journal article Changes in Plasma Renin Activity After Renal Artery Sympathetic Denervation (2021) Mahfoud F, Townsend RR, Kandzari DE, Kario K, Schmieder R, Tsioufis K, Pocock S, et al. Journal article